List view / Grid view

Dr Charlie Roco (Co-founder and Chief Technology Officer at Parse Biosciences)

 

news

Mapping lung disease: new atlas to accelerate drug discovery

Helmholtz Munich and Parse Biosciences have collaborated to create the…

16 September 2025 | By

Helmholtz Munich and Parse Biosciences have collaborated to create the world’s largest lung disease perturbation atlas – which could aid the discovery of new therapeutic targets and accelerate the development of future lung disease treatments.